Published • loading... • Updated
'It's still working': More are living with cancer as era of targeted drugs takes hold
Targeted therapies are helping turn some cancers into long-term conditions, with 16 million Americans now living after a cancer diagnosis, the American Cancer Society estimates.
- Cancer remains the nation's No. 2 cause of death behind heart disease, yet patient survival rates are rising as targeted therapies increasingly replace traditional chemotherapy.
- Unlike traditional chemotherapy, which kills all fast-growing cells, targeted drugs like Genentech's Herceptin are designed to block specific proteins that drive tumor growth.
- Cathy Smithwick, a patient living with cancer in Northern California, credits these advancements for her ability to continue traveling, noting she has experienced few side effects.
- The Huntsman Cancer Institute at the University of Utah supports the growing number of long-term patients through specialized care programs designed for extended survival.
- Researchers expect survival rates to continue climbing as doctors increasingly rely on genetic profiling to match patients with personalized drug therapies tailored to individual tumors.
Insights by Ground AI
23 Articles
23 Articles
'It's still working': More are living with cancer as era of targeted drugs takes hold
Cathy Smithwick has lived with breast cancer, and then ovarian cancer, for more than 20 years with the help of targeted drugs, drugs that harness the body's immune system, chemotherapy and hormone pills.
·New York, United States
Read Full ArticleCoverage Details
Total News Sources23
Leaning Left3Leaning Right0Center20Last UpdatedBias Distribution87% Center
Bias Distribution
- 87% of the sources are Center
87% Center
13%
C 87%
Factuality
To view factuality data please Upgrade to Premium
